查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475014

全球製药片剂包衣市场评估：依类型、依聚合物类型、依功能、依最终用户、依地区、机会、预测（2017-2031）

Pharma Tablet Coatings Market Assessment, By Type, By Polymer Type, By Functionality, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 238 Pages | 商品交期: 3-5个工作天内

价格

全球药品锭剂包衣市场规模预计将从 2023 年的 10.1 亿美元增至 2031 年的 16.2 亿美元，预计 2024-2031 年复合年增长率为 6.1%。 市场成长受到製药业扩张和研发活动增加的支持。

製药业的快速成长正在推动全球药品片剂包衣市场规模的扩大。 这种增长是由于世界不同地区各种疾病和病症的日益普及以及人口的快速增长。 例如，投资印度公司预测，到2030年，该国的製药业将达到1,300亿美元。 此外，对药品生产品质的日益关注和仿製药的日益采用为市场提供了利润丰厚的成长机会，并增加了对药片包衣的需求。 对各种辅料和药品的更严格监管进一步推动了市场扩张。

市场主要参与者增加投资来製造设备，帮助以具成本效益的方式及时交付可行的药片包衣，进一步推动市场成长。 此外，生物相似药因其成本效益而日益受欢迎，增加了各种治疗的可及性并改善了患者的生活质量，也推动了市场的扩张。 例如，安进生物相似药公司的《2022年生物相似药趋势报告》估计，过去三年推出的生物相似药的平均治疗领域占有率为75%。 生物相似药模仿参考生物製品的活性成分，并经过广泛的分析，以确认与参考生物製品存在相似的特性。 因此，生物相似药行业显示出显着增长，促使对药物片剂包衣的需求增加，对市场扩张产生积极影响。

仿製药扩散带动市场需求

仿製药的日益普及可归因于其成本效益以及人们对这些药物必须遵守的严格监管标准的认识不断增强。 要获得 FDA 的批准，仿製药必须与品牌药具有生物等效性。 这确保了两种药物的化学成分相同，儘管仿製药製造商可以将原厂药的活性成分改变 20%。 FDA 的容忍度高达 20%，但变化通常小于 4%。 消费者对仿製药须遵守的严格监管标准的认识不断提高，从而增强了对仿製药的信任。 例如，无障碍药物协会估计，美国大约 90% 的处方都是仿製药。 这增加了对药片包衣的需求并支持市场成长。

药片包衣技术的进步提供了利润丰厚的成长机会

引入新的製程分析技术 (PAT) 工具来收集数据并即时监控薄膜包衣操作是全球药物片剂包衣市场的新兴趋势。 各种 PAT 工具包括多种技术，例如用于监测薄膜涂覆操作的显微镜、光谱学和成像技术。 近年来，各种先进技术的成功开发提高了涂装作业的可扩展性。 例如，对拉曼光谱技术进行了各种改进，使其更易于使用、具有更紧凑的外形并提高了校准稳定性。 同样，罗格斯大学的研究小组全面评估了先进的多点近红外线空间分辨光谱 (SRS) 探头。 这些探头可实现快速、准确的测量。 该技术具有高效率和高精度，每小时可测试约 20 万片药片。 预计此类发展和进步将在预测期内为市场提供利润丰厚的成长机会。

本报告研究和分析了全球药品片剂包衣市场，提供市场规模和预测、市场动态、主要参与者的现状和前景等。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章顾客回馈

  • 市场认知度与产品讯息
  • 品牌知名度与忠诚度
  • 购买决策时考虑的因素
  • 购买频率
  • 购买介质

第五章全球药片包衣市场展望（2017-2031）

  • 市场规模与预测
    • 金额
    • 数量
  • 依类型
    • 糖衣
    • 薄膜涂层
    • 肠溶衣
    • 明胶涂层
    • 其他
  • 依聚合物型
    • 纤维素
    • 乙烯基
    • 亚克力
    • 其他
  • 功能性别
    • 延迟发布
    • 缓慢释放
  • 依最终用户
    • 医药
    • 营养补充品
  • 依地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第 6 章全球製药锭剂包衣市场展望：依地区划分（2017-2031 年）

  • 北美
    • 市场规模与预测
    • 依类型
    • 依聚合物型
    • 功能性别
    • 依最终用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第七章供给面分析

  • 生产能力：依公司划分
  • 生产：依公司划分
  • 营运效率：依公司划分
  • 主要工厂地点（最多 25 个地点）

第 8 章市场地图（2023 年）

  • 依类型
  • 依聚合物型
  • 功能性别
  • 依最终用户
  • 依地区

第九章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 供应链分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第十一章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家市场公司）
  • 专利分析（如果适用）

第十二章价格分析

第 13 章案例研究

第14章主要公司展望

  • NEHA LIFE SCIENCES PVT. LTD.
  • UPM Pharmaceuticals, Inc.
  • Evonik Industries
  • BASF Pharma
  • Colorcon
  • EasyCoat
  • METTLER TOLEDO
  • Lonza
  • Qualicaps
  • SPI Pharma

第 15 章策略建议

第16章关于我们公司，免责声明

Product Code: MX11281

Global pharma tablet coatings market is projected to witness a CAGR of 6.1% during the forecast period 2024-2031, growing from USD 1.01 billion in 2023 to USD 1.62 billion in 2031F. The growth of the market is supported by the expansion in the pharmaceutical sector and increasing research and development activities.

The rapid growth of the pharmaceutical sector is boosting the global pharma tablet coatings market size. The growth can be attributed to the increasing prevalence of various diseases and disorders and exponential rise in population in various regions across the globe. For instance, Invest India estimated that the pharmaceutical industry in the country is expected to reach USD 130 billion by 2030. Moreover, the increasing emphasis on the quality of pharmaceutical products manufacturing and rising adoption of generic drugs provide lucrative growth opportunities to the market, boosting the requirement for pharma tablet coatings. The increase in stringency by regulatory bodies regarding different excipients and drugs further bolstered the market expansion.

The rising investments by key players in the market to produce equipment that supports the delivery of viable pharma tablet coatings cost-efficient and timely are further propelling the global pharma tablet coatings market growth. Additionally, the rising popularity of biosimilars owing to their cost-effective nature, which increases the accessibility to various treatments and improves the quality of life of the patients, is supporting the expansion of the market for tablet coatings. For instance, 2022 Biosimilar Trends Report by Amgen Biosimilars estimates that for the biosimilars launched in the past three years, in the therapeutic areas, average share was 75%. Biosimilars mimic the active ingredient in the reference biologic and undergo extensive analysis to confirm the presence of similar characteristics to that of the reference biologics. Thus, the biosimilars sector is witnessing significant growth, which in turn is boosting the requirement for pharma tablet coatings and positively influencing the expansion of the market.

Increasing Adoption of Generics Boost Global Pharma Tablet Coatings Market Demand

The growing popularity of generics can be attributed to their cost-effective nature and the rising awareness of strict regulatory standards these drugs must follow. To receive the stamp of approval from the FDA, the generic drugs must be bioequivalent to their brand-name counterpart. It ensures that two drugs are chemically the same, though the makers of the generic medication are allowed a variation of twenty percent in the active ingredient from the original formula. Even though the wiggle room allowed by the FDA is up to 20%, variations of less than 4% are usually observed. Due to the increasing awareness among the general population about such strict regulatory standards followed by generic medications has boosted confidence in such drugs. For instance, the Association for Accessible Medicines estimates that approximately 90% of the prescriptions dispensed in the United States are of generics. Thus boosting the demand for pharma-coating tablets and supporting the market's growth.

Technological Advancements in Pharma Tablet Coatings Provide Lucrative Growth Opportunities

Introducing new process analytical technology (PAT) tools for data acquisition and real-time monitoring for filming coating operations is an emerging global pharma tablet coatings market trend. Various PAT tools include a wide range of techniques, such as microscopic techniques, spectroscopic techniques, and imaging techniques, to monitor the film coating operations. Recently, the successful development of various advanced technologies has aided in enhancing the scalability of the coating operations. For instance, the Raman spectroscopy technology underwent various improvements to make it more user-friendly, achieving a more compact form factor, and enhance the calibration stability. Similarly, a research group at Rutgers University comprehensively evaluated advanced multi-point NIR spatially resolved spectroscopy (SRS) probes. These probes provide rapid and precise measurements. The high efficiency and precision offered by this technology has allowed the inspection of approximately 200,000 tablets per hour. Such developments and advancements will provide lucrative growth opportunities to the market over the forecast period.

North America Accounts for a Significant Share of the Market

The growth of North America pharma tablet coatings market can be attributed to the rapid expansion of pharmaceutical sector in the region, strong presence of various leading market players, and increasing prevalence of several diseases and disorders. The rising investments by the market players based in the region towards the development of novel products and technologies are further aiding the growth of the market in North America.

For instance, in May 2023, Colorcon, headquartered in Pennsylvania, United States, introduced titanium dioxide-free film coating designed to mitigate the challenges associated with moisture-sensitive actives. Colorcon launched an Opadry film coating system that meets the moisture management requirements of pharmaceutical tablets without utilizing titanium dioxide. Through their portfolio of Opadry complete film coating systems, the company provides scope for reducing time-to-market and complexity by providing high-quality products to their customers. They are focused on carefully selecting ingredients that meet the local pharmaceutical regulatory requirements. Such regional developments will provide lucrative growth opportunities for the North American market.

Sustained Release Holds Significant Share of the Market

The growth of the segment can be attributed to the increasing prevalence of various diseases and disorders that require sustained and controlled release of drugs, including hypertension, diabetes, and asthma. For instance, the International Diabetes Federation estimated that, in 2021, approximately 10.5% of the adult population, i.e., individuals between the age of 20-79 years had diabetes. Also, by 2045 the number of cases of diabetes will witness an increase of 46% and 1 in 8 adults, about 783 million individuals will be living with diabetes. The increase in prevalence of diabetes will boost the requirement for sustained release pharma tablet costings, augmenting the market's growth.

Additionally, the utilization of sustained-release tablets offers various advantages, including slow drug release in the bloodstream, which allows for maintaining a constant level of medication in the bloodstream and removes the likelihood of burst drug release. Thus, it boosts demand and propels the market expansion.

Pharmaceutical Sector Accounts for Significant Market Share

The expansion of the pharmaceutical sector can be attributed to the exponential growth of the geriatric population, the increase in the prevalence of several diseases, and rising healthcare expenditure in various countries across the globe. Due to the growth, the requirement for pharma tablet coatings is increasing, augmenting the market demand. Additionally, the demand for tablet coatings by the pharmaceutical sector is augmenting as the prevalence of diseases that require tablet formulations as the primary form of treatment rises.

For instance, the rise in the number of cases of arthritis is boosting the demand for global pharma tablet coatings. According to the estimates of the Centers for Disease Control and Prevention, an estimated 53.2 million adults in the United States, approximately 21.2% of the population, have been diagnosed by a doctor to have some form of arthritis in 2023. The increase in the number of cases of arthritis is providing lucrative growth opportunities to the market as various corticosteroid medications are consumed as pills for slowing the joint damage and reducing pain and inflammation. Thus, boosting the requirement for pharma tablet coatings and supporting the expansion of the market.

Future Market Scenario (2024 - 2031F)

According to global pharma tablet coatings market analysis, the increasing emphasis on nanocoating technology will support the expansion of the market in the coming years. The growing utilization of nanotechnology will aid in enhancing the capabilities of the excipients. Nanocoating will aid in improving drug release profiles by enhancing the bioavailability of active pharmaceutical ingredient and controlling the release rate. Furthermore, the utilization of nanocoating technology will support the incorporation of different functional materials including antimicrobial agents, flavoring agents, antioxidants, and polymers, onto the surface of the tablet. The increasing utilization of nanocoating technology will provide various benefits and support the expansion of the market for pharma tablet coatings over the forecast period.

Key Players Landscape and Outlook

The increasing investments by the leading pharma tablet coatings market players towards the development of new coating manufacturing facilities will support the global pharma tablet coatings market growth. For instance, Colorcon is investing in the development of a new manufacturing facility in Johor State, Malaysia, through their subsidiary, Colorcon Malaysia. The facility will be producing advanced and high-quality film-coating products to cater to the requirements of nutraceutical and pharmaceutical manufacturers across the region of the Southeast Asia, comprising of New Zealand and Australia. With an investment of approximately USD 50 million, the strategic approach of Colorcon to be located closer to their customers will boost the ability of the company to cater to the expected growth in the region. Thus, increase in such investments over the forecast period will provide lucrative growth opportunities for the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Pharma Tablet Coatings Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Type
    • 5.2.1.Sugar Coated
    • 5.2.2.Film Coated
    • 5.2.3.Enteric Coated
    • 5.2.4.Gelatin Coated
    • 5.2.5.Others
  • 5.3.By Polymer Type
    • 5.3.1.Cellulosic
    • 5.3.2.Vinyl
    • 5.3.3.Acrylic
    • 5.3.4.Others
  • 5.4.By Functionality
    • 5.4.1.Delayed-Release
    • 5.4.2.Sustained-Release
  • 5.5.By End-user
    • 5.5.1.Pharmaceutical
    • 5.5.2.Nutraceutical
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East and Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Pharma Tablet Coatings Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Type
      • 6.1.2.1.Sugar Coated
      • 6.1.2.2.Film Coated
      • 6.1.2.3.Enteric Coated
      • 6.1.2.4.Gelatin Coated
      • 6.1.2.5.Others
    • 6.1.3.By Polymer Type
      • 6.1.3.1.Cellulosic
      • 6.1.3.2.Vinyl
      • 6.1.3.3.Acrylic
      • 6.1.3.4.Others
    • 6.1.4.By Functionality
      • 6.1.4.1.Delayed-Release
      • 6.1.4.2.Sustained-Release
    • 6.1.5.By End-user
      • 6.1.5.1.Pharmaceutical
      • 6.1.5.2.Nutraceutical
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
        • 6.1.6.1.1.By Value
        • 6.1.6.1.2.By Volume
      • 6.1.6.2.By Type
        • 6.1.6.2.1.Sugar Coated
        • 6.1.6.2.2.Film Coated
        • 6.1.6.2.3.Enteric Coated
        • 6.1.6.2.4.Gelatin Coated
        • 6.1.6.2.5.Others
      • 6.1.6.3.By Polymer Type
        • 6.1.6.3.1.Cellulosic
        • 6.1.6.3.2.Vinyl
        • 6.1.6.3.3.Acrylic
        • 6.1.6.3.4.Others
      • 6.1.6.4.By Functionality
        • 6.1.6.4.1.Delayed-Release
        • 6.1.6.4.2.Sustained-Release
      • 6.1.6.5.By End-user
        • 6.1.6.5.1.Pharmaceutical
        • 6.1.6.5.2.Nutraceutical
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East and Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Type
  • 8.2.By Polymer Type
  • 8.3.By Functionality
  • 8.4.By End-user
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.NEHA LIFE SCIENCES PVT. LTD.
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.UPM Pharmaceuticals, Inc.
  • 14.3.Evonik Industries
  • 14.4.BASF Pharma
  • 14.5.Colorcon
  • 14.6.EasyCoat
  • 14.7.METTLER TOLEDO
  • 14.8.Lonza
  • 14.9.Qualicaps
  • 14.10.SPI Pharma

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 3.Global Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 4.Global Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 5.Global Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 6.Global Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Pharma Tablet Coatings Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 10.North America Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 11.North America Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 12.North America Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 13.North America Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 17.United States Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 18.United States Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 19.United States Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 20.United States Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 23.Canada Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 24.Canada Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 25.Canada Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 26.Canada Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 29.Mexico Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 30.Mexico Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 31.Mexico Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 32.Mexico Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 35.Europe Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 36.Europe Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 37.Europe Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 38.Europe Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 42.Germany Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 43.Germany Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 44.Germany Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 45.Germany Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 48.France Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 49.France Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 50.France Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 51.France Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 54.Italy Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 55.Italy Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 56.Italy Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 57.Italy Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 60.United Kingdom Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 61.United Kingdom Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 62.United Kingdom Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 63.United Kingdom Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 66.Russia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 67.Russia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 68.Russia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 69.Russia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 72.Netherlands Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 73.Netherlands Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 74.Netherlands Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 75.Netherlands Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 78.Spain Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 79.Spain Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 80.Spain Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 81.Spain Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 84.Turkey Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 85.Turkey Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 86.Turkey Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 87.Turkey Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 90.Poland Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 91.Poland Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 92.Poland Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 93.Poland Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 96.South America Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 97.South America Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 98.South America Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 99.South America Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 103.Brazil Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 104.Brazil Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 105.Brazil Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 106.Brazil Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 109.Argentina Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 110.Argentina Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 111.Argentina Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 112.Argentina Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 115.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 116.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 117.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 118.Asia-Pacific Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 120.India Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 122.India Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 123.India Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 124.India Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 125.India Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 128.China Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 129.China Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 130.China Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 131.China Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 134.Japan Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 135.Japan Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 136.Japan Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 137.Japan Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 140.Australia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 141.Australia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 142.Australia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 143.Australia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 146.Vietnam Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 147.Vietnam Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 148.Vietnam Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 149.Vietnam Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 152.South Korea Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 153.South Korea Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 154.South Korea Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 155.South Korea Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 158.Indonesia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 159.Indonesia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 160.Indonesia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 161.Indonesia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 164.Philippines Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 165.Philippines Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 166.Philippines Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 167.Philippines Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 170.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 171.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 172.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 173.Middle East & Africa Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 177.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 178.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 179.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 180.Saudi Arabia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 183.UAE Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 184.UAE Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 185.UAE Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 186.UAE Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 189.South Africa Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 190.South Africa Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 191.South Africa Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 192.South Africa Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Polymer Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023